Targeting Head and Neck Cancer Stem Cells: Current Advances and Future Challenges

Por Birkeland, A.C., Owen, J.H., Prince, M.E.
Publicado no J Dent Res (2015)

Rationale for the Advancement of PI3K Pathway Inhibitors for Personalized Chordoma Therapy

Por Michmerhuizen, N.L., Owen, J.H., Heft Neal, M.E., Mann, J.E., Leonard, E., Wang, J., Zhai, J., Jiang, H., McHugh, J.B., Brenner, J.C., Prince, M.E.P.
Publicado no J Neurooncol (2020)

Evaluation of CD44 variants expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance

Por Athanassiou-Papaefthymiou, M., Shkeir, O., Kim, D., Divi, V., Matossian, M., Owen, J. H., Czerwinski, M. J., Papagerakis, P., McHugh, J., Bradford, C. R., Carey, T. E., Wolf, G. T., Prince, M. E., Papagerakis, S.
Publicado no Int J Immunopathol Pharmacol (2014)